Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degenerations.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03225131
What this trial is testing

Dark Adaptation in Participants With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 57
Early research (Phase 1)Study completedNCT01051700
What this trial is testing

A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans

Who this might be right for
Macular Degeneration
GlaxoSmithKline 72
Early research (Phase 1)Looking for participantsNCT07662096
What this trial is testing

A First-In-Human Study of ARO-033 in Adult Participants

Who this might be right for
Age-related Macular Degeneration
Arrowhead Pharmaceuticals 84
Not applicableStudy completedNCT00592826
What this trial is testing

HMP (Home Macular Perimeter) -Usability Trial

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT00467935
What this trial is testing

Scotoma Reduction in AMD Patients Treated With Ranibizumab

Who this might be right for
Macular Degeneration
Retina Research Foundation 20
Early research (Phase 1)Study completedNCT03316521
What this trial is testing

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Who this might be right for
Complement Mediated Diseases
Amyndas Pharmaceuticals S.A. 50
Not applicableStudy completedNCT03076697
What this trial is testing

Smartphone Screening for Eye Diseases

Who this might be right for
Diabetes MellitusGlaucomaAge Related Macular Degeneration+3 more
University of Michigan 472
Not applicableLooking for participantsNCT07446582
What this trial is testing

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

Who this might be right for
Age-Related (Dry) Macular Degeneration
AI-Spectral 1,000
Post-approval studies (Phase 4)Study completedNCT02689518
What this trial is testing

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Who this might be right for
Macular DegenerationWet Macular Degeneration
University of California, San Diego 50
Not applicableStudy completedNCT03728660
What this trial is testing

Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System

Who this might be right for
Low Vision
Johns Hopkins University 88
Large-scale testing (Phase 3)Ended earlyNCT00890097
What this trial is testing

Geographic Atrophy Treatment Evaluation

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Alcon Research 772
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Not applicableLooking for participantsNCT07338461
What this trial is testing

High Resolution Imaging OCT Study

Who this might be right for
Normal EyesAge Related Macular DegenerationDiabetic Retinopathy+1 more
Heidelberg Engineering GmbH 97
Large-scale testing (Phase 3)Study completedNCT00429962
What this trial is testing

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
University Hospital, Basel, Switzerland 40
Not applicableStudy completedNCT01880788
What this trial is testing

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy
Sequenom, Inc. 152
Testing effectiveness (Phase 2)Study completedNCT01914159
What this trial is testing

Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

Who this might be right for
Age Related Macular Degeneration
University Hospital, Bonn 24
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 197
Testing effectiveness (Phase 2)Study completedNCT00363714
What this trial is testing

A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Allergan 26
Next Page